Healthcare Market Research Reports

The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.

Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....

Key Topics Covered in Healthcare:

Drug Development & Innovation:

  • Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
  • Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
  • Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
  • Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.

Digital Health & Telehealth:

  • Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
  • Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
  • Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
  • Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
  • Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.

Medical Devices & Diagnostics:

  • Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
  • Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
  • Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
  • Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
  • Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
  • Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
  • Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
  • Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
  • Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
  • Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
  • Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.

Other Healthcare Growth Areas:

  • Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
  • Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.

Clinical Trials & Drug Development Services:

  • Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
  • Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.

Biopharmaceutical Products:

  • Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
  • Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.

For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.

  1. 09 Apr 2013  |  Global  |  Market Research

    The Future of Biopharmaceutical Contract Manufacturing in Europe - What Underpins the Success of CMOs?

    European Biopharmaceutical Contract Manufacturing Market

    This issue of Vital Signs, released in July 2015, discusses Affmetrix's acquisition of Eureka Genomics, OPKO Health's acquisition of Bio-Reference Laboratories, CVS Health's acquisition of Target's in-store pharmacies and clinics, and Thermo Fisher Scientific's acquisition of Alfa Aesar.

    $1,500.00

    Special Price $1,125.00 save 25 %

  2. 26 Mar 2013  |  Global  |  Market Research

    Strategic Analysis of Antiviral Drug Development for Viral Hepatitis and HIV/AIDS

    Persistent Unmet Need Fuels Antiviral Drug Development for Bloodborne Pathogens

    This research service focuses on antiviral/antiretroviral therapeutics for the treatment of infection with blood-borne pathogens of current global interest, specifically viral hepatitis and HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HBV, HCV, and H...

    $1,500.00

    Special Price $1,125.00 save 25 %

  3. 21 Mar 2013  |  Global  |  Market Research

    Strategic Analysis of Anti-obesity Prescription Drug Development

    Recent Marketing Approvals Revive Hope for Successful Treatment Options

    This research service focuses on prescription drugs for the treatment of obesity. A global product and pipeline assessment is provided for marketed and investigational products. Segmentation by drug class is provided, along with additional supporting information, such as clinical trial timelines and results, historical and projected launch timeline...

    $1,500.00

    Special Price $1,125.00 save 25 %

  4. 22 Feb 2013  |  Global  |  Market Research

    Financial Assessment of the Global Pharmaceutical and Biotechnology Industry

    Financial Management is the Key Strategy for Sustainability

    This research service presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type, and region. It addresses the major issues and challenges, unmet needs, and emerging trends in the market. Detailed information has been provided on s...

    $4,950.00

    Special Price $3,712.50 save 25 %

  5. This issue of Vital Signs discusses the change in 2015 Mammogram Guidelines, NeoGenomics' acquistion of Clarient from GE, and Tute Genomics' acquisition of Knome.

    $1,500.00

    Special Price $1,125.00 save 25 %

  6. This issue of Vital Signs, released in August 2015, discusses The Real Fight Against Cancer: The Struggle to make Drugs Affordable, OPKO Health's acquisition of Bio-Reference Laboratories, Health Insurance Company Mergers  How will Consumers Fare?, and Illumina's acquisition of GenoLogics.

    $1,500.00

    Special Price $1,125.00 save 25 %

  7. 25 Jan 2013  |  Global  |  Market Research

    GIL-100 Sales and Investment Attractiveness Index for Healthcare

    Country Attractiveness for Healthcare

    Where should one invest or sell in the aftermath of the financial crisis of 2008 and the on-going European debt crisis? While rich countries have shown very slow growth rates, emerging markets have shown much greater resilience. To increase profitability, you can either find new markets to increase sales, or seek opportunities to invest. Emerging ...

    $1,500.00

    Special Price $1,125.00 save 25 %